DPP4 and neoplasm: We have previously showed that the nuclear localization of CD26 is functionally involved in the anti-tumor process following the YS110 treatment and that the nuclear translocation of CD26 and YS110 contributes to growth inhibition of malignant mesothelioma cells after the YS110 treatment [13].